BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

544611

MAHALIFE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Mahamaya Lifesciences Ltd Share Price Update

As of the latest trading session, Mahamaya Lifesciences Ltd share price is currently at ₹ 113.2, which is down by ₹ -2.80 from its previous closing. Today, the stock has fluctuated between ₹ 111.00 and ₹ 116.00. Over the past year, Mahamaya Lifesciences Ltd has achieved a return of [-] %. In the last month alone, the return has been [-] %. Read More...

Investment Returns

Over 1 Month 0.0% Over 3 Months 0.0% Over 6 Months 0.0% Over 1 Year 0.0%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Mahamaya Lifesciences Ltd fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    0.0

  • P/E Ratio (TTM)

    0.0

  • Beta

    0.0

  • Book Value / share

    0.0

  • Return on equity

    0.0%

  • EPS (TTM)

    0.0

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.0

info icon alternate text

Mahamaya Lifesciences Ltd Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 161.52
Operating Expense 155.29
Net Profit 5.47
Net Profit Margin (%) 3.38
Earnings Per Share (EPS) 43.80
EBITDA 14.35
Effective Tax Rate (%) 27.26
Particulars MAR 2023 (Values in Cr)
Revenue 137.02
Operating Expense 132.18
Net Profit 3.73
Net Profit Margin (%) 2.72
Earnings Per Share (EPS) 29.85
EBITDA 9.15
Effective Tax Rate (%) 28.40
Particulars MAR 2022 (Values in Cr)
Revenue 89.91
Operating Expense 86.14
Net Profit 2.80
Net Profit Margin (%) 3.11
Earnings Per Share (EPS) 22.44
EBITDA 6.27
Effective Tax Rate (%) 28.86
Particulars MAR 2025 (Values in Cr)
Book Value / Share 27.82
ROE % 34.93
ROCE % 25.79
Total Debt to Total Equity 1.52
EBITDA Margin 9.83
Particulars MAR 2024 (Values in Cr)
Book Value / Share 197.46
ROE % 23.67
ROCE % 21.04
Total Debt to Total Equity 1.79
EBITDA Margin 8.97
Particulars MAR 2023 (Values in Cr)
Book Value / Share 155.67
ROE % 21.34
ROCE % 20.05
Total Debt to Total Equity 1.24
EBITDA Margin 6.73
Particulars MAR 2022 (Values in Cr)
Book Value / Share 125.77
ROE % 17.31
ROCE % 15.20
Total Debt to Total Equity 1.22
EBITDA Margin 7.02
Particulars MAR 2025 (Values in Cr)
Book Value / Share 28.07
ROE % 34.16
ROCE % 25.56
Total Debt to Total Equity 1.50
EBITDA Margin 9.73
Particulars MAR 2024 (Values in Cr)
Book Value / Share 201.64
ROE % 24.37
ROCE % 21.29
Total Debt to Total Equity 1.76
EBITDA Margin 9.08
Particulars MAR 2023 (Values in Cr)
Book Value / Share 157.84
ROE % 18.92
ROCE % 17.89
Total Debt to Total Equity 1.24
EBITDA Margin 6.75
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 3.99
Total Assets 188.35
Total Liabilities 188.35
Total Equity 49.42
Share Outstanding 17766200
Price to Book Ratio 0.00
Return on Assets (%) 6.87
Return on Capital (%) 12.04
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.01
Total Assets 112.06
Total Liabilities 112.06
Total Equity 24.65
Share Outstanding 1248750
Price to Book Ratio 0.00
Return on Assets (%) 4.65
Return on Capital (%) 6.58
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.04
Total Assets 77.88
Total Liabilities 77.88
Total Equity 19.43
Share Outstanding 1248750
Price to Book Ratio 0.00
Return on Assets (%) 4.81
Return on Capital (%) 8.56
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.36
Total Assets 55.71
Total Liabilities 55.71
Total Equity 15.70
Share Outstanding 1248750
Price to Book Ratio 0.00
Return on Assets (%) 4.88
Return on Capital (%) 7.81
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 3.91
Total Assets 188.71
Total Liabilities 188.71
Total Equity 49.86
Share Outstanding 17766200
Price to Book Ratio 0.00
Return on Assets (%) 6.79
Return on Capital (%) 11.88
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.01
Total Assets 112.48
Total Liabilities 112.48
Total Equity 25.18
Share Outstanding 1248750
Price to Book Ratio 0.00
Return on Assets (%) 4.86
Return on Capital (%) 6.85
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.40
Total Assets 78.27
Total Liabilities 78.27
Total Equity 19.71
Share Outstanding 1248750
Price to Book Ratio 0.00
Return on Assets (%) 4.76
Return on Capital (%) 8.46
Particulars MAR 2025 (Values in Cr)
Net Income 17.35
Cash from Operations 2.79
Cash from Investing -8.28
Cash from Financing 8.52
Net change in Cash 0.76
Free Cash Flow 11.66
Particulars MAR 2024 (Values in Cr)
Net Income 7.11
Cash from Operations -21.56
Cash from Investing -2.00
Cash from Financing 24.34
Net change in Cash -0.31
Free Cash Flow -19.19
Particulars MAR 2023 (Values in Cr)
Net Income 5.09
Cash from Operations 2.17
Cash from Investing -2.85
Cash from Financing 2.35
Net change in Cash 0.62
Free Cash Flow 5.07
Particulars MAR 2022 (Values in Cr)
Net Income 3.72
Cash from Operations 3.36
Cash from Investing -3.25
Cash from Financing 1.37
Net change in Cash 0.28
Free Cash Flow 6.63
Particulars MAR 2025 (Values in Cr)
Net Income 17.26
Cash from Operations -1.48
Cash from Investing -4.43
Cash from Financing 8.46
Net change in Cash 0.68
Free Cash Flow 3.55
Particulars MAR 2024 (Values in Cr)
Net Income 7.52
Cash from Operations -22.27
Cash from Investing -1.37
Cash from Financing 24.52
Net change in Cash -0.31
Free Cash Flow -20.76
Particulars MAR 2023 (Values in Cr)
Net Income 5.20
Cash from Operations 2.02
Cash from Investing -2.77
Cash from Financing 2.59
Net change in Cash 0.62
Free Cash Flow 4.92
Company Name Price P/E P/B Market Cap 52 Week Low/High
COROMANDEL INTERNTL. LTD 2216.25 30.73 5.36 65361.89 1590.00 / 2720.00
GUJ STATE FERT & CHEM LTD 196.45 11.71 0.62 7828.09 156.50 / 231.35
SPIC LTD 92.10 10.09 1.44 1875.52 66.25 / 128.10
RASHTRIYA CHEMICALS & FER 151.80 27.06 1.70 8374.65 108.05 / 188.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
COROMANDEL INTERNTL. LTD 2216.25 30.23 5.40 65361.89 1590.00 / 2720.00
GUJ STATE FERT & CHEM LTD 196.45 12.27 0.63 7828.09 156.50 / 231.35
MANGALORE CHEMICALS & FERTILIZ 308.40 22.64 3.43 3655.16 125.25 / 373.10
SPIC LTD 92.10 11.73 1.65 1875.52 66.25 / 128.10

Mahamaya Lifesciences Ltd shareholding pattern

Holding

Others
22.72%
Promoter Holdings
77.27%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Mr. Krishnamurthy Ganesan 5486250.0 (30.88%) Shareholding of Promoter and Promoter Group
Mr. Prashant Krishnamurthy 4120875.0 (23.2%) Shareholding of Promoter and Promoter Group
Mrs. Lalitha Krishnamurthy 4120875.0 (23.2%) Shareholding of Promoter and Promoter Group
Pink Tiger Alliances LLP 2422200.0 (13.63%) Public Shareholding
Minerva Ventures Fund 534000.0 (3.01%) Public Shareholding
Multiplier Share Stock Advisors Private Limited 300000.0 (1.69%) Public Shareholding
Khazana Tradelinks Private Limited 120000.0 (0.68%) Public Shareholding
Bikramjit Singh Kandhari 120000.0 (0.68%) Public Shareholding
Siddharth Iyer 120000.0 (0.68%) Public Shareholding
Moheet Vinodkuamar Agrawal 120000.0 (0.68%) Public Shareholding
Ajith Kumar Mittal 100000.0 (0.56%) Public Shareholding
Jyoti Ketan Vakharia 60000.0 (0.34%) Public Shareholding
Sandeep Shridhar Ghate 60000.0 (0.34%) Public Shareholding
Ruchi Ghanashyam 20000.0 (0.11%) Public Shareholding
Girraj Kumar Gupta 20000.0 (0.11%) Public Shareholding
Rajeev Kumar Gupta 20000.0 (0.11%) Public Shareholding
Kozhissery Jagadeesh Chandran 12000.0 (0.07%) Public Shareholding
Meenakshi Sharma 10000.0 (0.06%) Public Shareholding

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

News

Left Arrow
Right Arrow

Mahamaya Lifesciences Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
116.00 1.75 redarrow
red-green-graph indicator
0 Bearish
0 Bullish
  • 5 Days 0.00
  • 26 Days 0.00
  • 10 Days 0.00
  • 50 Days 0.00
  • 12 Days 0.00
  • 100 Days 0.00
  • 20 Days 0.00
  • 200 Days 0.00
0.0 PIVOT

First Support

0.0

First Resistance

0.0

Second Support

0.0

Second Resistance

0.0

Third Support

0.0

Third Resistance

0.0

RSI

0.0

ADX

0.0

MACD

0.0

Williams % R

0.0

Commodity Channel Index (CCI)

0.0

Date

[-]

Week

0.0

Same Day

0.0

Month

0.0

1 Year

0.0

3 Year

0.0

Over 1 Month

0.0%

down

Over 1 Year

0.0%

down

Over 3 Months

0.0%

down

Over 3 Years

0.0%

down

Over 6 Months

0.0%

down

Over 5 Years

0.0%

down

Mahamaya Lifesciences Ltd Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Mahamaya Lifesciences Ltd Share Price

Mahamaya Lifesciences Limited was originally incorporated as a private limited Company under the name of 'Mahamaya Life Sciences Private Limited' by the Assistant Registrar of Companies, NCT Delhi & Haryana, on May 07, 2002. Further, Company name was changed from 'Mahamaya Life Sciences Private Limited' to 'Mahamaya Lifesciences Private Limited' and a fresh Certificate of Incorporation dated February 15, 2016 was issued by the Registrar of Companies, Delhi. The Company status was changed to Public Limited Company and the name of the Company was changed to Mahamaya Lifesciences Limited on November 19, 2024 by the Registrar of Companies, Central Processing Centre.

The Company specializes in manufacturing of pesticide formulations and supply bulk formulations catering to both Indian agrochemical companies, as well as multinational corporations (MNCs). The Company began the journey by focusing on import and registration of vital pesticide molecules (Technical) that were not produced domestically in India. It imported these molecules after lot of product research and worked on registering them with the Central Insecticides Board and Registration Committee (CIBRC) under the Department of Agriculture, Government of India. After successful registration, it marketed these molecules both as technical and as value added end use formulations for both domestic manufacturers and MNCs.

In 2002, Company expanded from the sale of technical to companies, to establish its own manufacturing plant for formulations in December 2021, located in Dahej, Gujarat. From this manufacturing facility, it produce and sell bulk formulations, branded products (own brand products), and export them to customers. Domestically, it market the own branded products across states such as Punjab, Haryana, Rajasthan, Uttar Pradesh, Gujarat, Maharashtra, Andhra Pradesh, and Telangana through a well-established dealer network. Internationally, it export the products to countries including the Dominican Republic, Turkey, Egypt, and the UAE.

The Company has introduced Norwegian seaweed extract based Bio-stimulants formulations. Company is focused on diversifying its portfolio by adding more products in bio-product category. The expansion of bio-products in agriculture is a critical strategy to meet the growing demand for sustainable and eco-friendly agricultural solutions. Company also incorporated a subsidiary in UAE named Mahamaya Lifesciences FZE to further promote the import and export operations through this subsidiary in 2017.

The Company is planning an IPO of 61,78,800 Equity Shares of Rs 10/- each comprising a fresh issue of 56,38,800 Equity Shares and 5,40,000 Equity Shares through offer for sale.

Parent organization Indian Private
NSE symbol [-]
Founded 2002
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of MAHAMAYA LIFESCIENCES LIMITED?

Answer Field

MAHAMAYA LIFESCIENCES LIMITED share price is for NSE ₹ 0.00 & for BSE ₹ 113.20 as on Nov 19 2025 09:23 AM.

What is the Market Cap of MAHAMAYA LIFESCIENCES LIMITED Share?

Answer Field

The market cap of MAHAMAYA LIFESCIENCES LIMITED for NSE ₹ 0.00 & for BSE ₹ 201.11 as on Nov 19 2025 09:23 AM.

What is the 52 Week High and Low of MAHAMAYA LIFESCIENCES LIMITED?

Answer Field

The 52 Week High and Low of MAHAMAYA LIFESCIENCES LIMITED for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 121.80 and ₹ 111.00.

What is 1 year return for MAHAMAYA LIFESCIENCES LIMITED?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of MAHAMAYA LIFESCIENCES LIMITED Share?

Answer Field

As on Nov 19 2025 09:23 AM the price-to-earnings (PE) ratio for MAHAMAYA LIFESCIENCES LIMITED share is 0.0.

What is the PB ratio of MAHAMAYA LIFESCIENCES LIMITED Share?

Answer Field

As on Nov 19 2025 09:23 AM, the price-to-book (PB) ratio for MAHAMAYA LIFESCIENCES LIMITED share is 0.0.

How to Buy MAHAMAYA LIFESCIENCES LIMITED Share?

Answer Field

You can trade in MAHAMAYA LIFESCIENCES LIMITED shares with Bajaj Broking by opening a demat account.

How to Buy MAHAMAYA LIFESCIENCES LIMITED Share on Bajaj Broking App?

Answer Field

To buy MAHAMAYA LIFESCIENCES LIMITED shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “MAHAMAYA LIFESCIENCES LIMITED”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59